United States · FDA National Drug Code directory
Atovaquone and Proguanil HCl
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-2980_db61f577-1818-4643-8712-23db5c162ae6
- Product NDC
- 50090-2980
- Form
- TABLET, FILM COATED
- Composition / generic term
- atovaquone and proguanil hydrochloride
- Labeler
- A-S Medication Solutions
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20120727
- Source listing expiry
- 20261231
Source-listed ingredients
- ATOVAQUONE — 250 mg/1
- PROGUANIL HYDROCHLORIDE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 7 TABLET, FILM COATED in 1 BOTTLE (50090-2980-0) · 50090-2980-0
- 12 TABLET, FILM COATED in 1 BOTTLE (50090-2980-1) · 50090-2980-1
- 14 TABLET, FILM COATED in 1 BOTTLE (50090-2980-2) · 50090-2980-2
- 16 TABLET, FILM COATED in 1 BOTTLE (50090-2980-3) · 50090-2980-3
- 24 TABLET, FILM COATED in 1 BOTTLE (50090-2980-4) · 50090-2980-4
- 5 TABLET, FILM COATED in 1 BOTTLE (50090-2980-5) · 50090-2980-5
- 10 TABLET, FILM COATED in 1 BOTTLE (50090-2980-6) · 50090-2980-6
- 100 TABLET, FILM COATED in 1 BOTTLE (50090-2980-7) · 50090-2980-7
- 20 TABLET, FILM COATED in 1 BOTTLE (50090-2980-8) · 50090-2980-8
- 30 TABLET, FILM COATED in 1 BOTTLE (50090-2980-9) · 50090-2980-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →